Design Therapeutics(DSGN)

Focus: Design Therapeutics is a public-stage biotech company focused on drugs targeting disorders caused by nucleotide-repeat expansions, operating across oncology, neurology, and infectious diseases. With 201-500 employees based in Carlsbad, CA, the company is advancing a diversified pipeline spanning multiple therapeutic modalities.

Oncology Neurology Infectious Diseases Cardiovascular

Profile data last refreshed 17h ago · AI intelligence enriched 2w ago

Funding Stage

PUBLIC

Employees

201-500

Open Jobs

About Design Therapeutics

AI assessmentNot Hiring

No open roles listed right now. Follow Design Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

2/9 — Limited

Company HealthStrong

Pipeline

Early-stage

50 total

LOE Risk

Protected

No near-term cliffs

Hiring

Stable

Revenue

$0K

Key Products

DT-216P2

Friedreich Ataxia

Growth

Phase 1/2 program targeting a rare genetic disorder aligns with company's core nucleotide-repeat expansion thesis.

DT-168

Fuchs Endothelial Corneal Dystrophy

Help build intelligence for Design Therapeutics

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Pipeline & Clinical Trials

Development of a Decision Aid to Facilitate Ovarian Cancer Patient's Choices Regarding Biomarker CA1

Ovarian Cancer

N/A

Clinical Trials (1)

NCT03004391Development of a Decision Aid to Facilitate Ovarian Cancer Patient's Choices Regarding Biomarker CA125

N/A

Etanercept Survival in Elderly Population

Psoriasis

N/A

Clinical Trials (1)

NCT02503059Etanercept Survival in Elderly Population

N/A

COMMIT mHealth application

Depression

N/A

Clinical Trials (1)

NCT04510909COMMIT Depression Trial Nepal

N/A

Antiplatelet Therapy in Acute Coronary Syndrome(ACS). Safety and Efficacy of Switching Antiplatelet

Acute Coronary Syndrome

N/A

Clinical Trials (1)

NCT02500290Antiplatelet Therapy in Acute Coronary Syndrome(ACS). Safety and Efficacy of Switching Antiplatelet

N/A

Self monitoring of blood pressure using Health Gauge Device and monthly monitoring of weight gain

Hypertension, Pregnancy-Induced

N/A

Clinical Trials (1)

NCT03858595Optimizing Gestational Weight Gain, Birth Weight and Other Perinatal Outcomes Among Pregnant Women at Risk of Hypertension in Pregnancy

N/A

Knee OA Brace

Knee Osteoarthritis

N/A

Clinical Trials (1)

NCT01886144Effects of Bracing on Knee Osteoarthritis (OA)

N/A

Miraπ

Stroke

N/A

Clinical Trials (1)

NCT06296628Rehabilitation Device for Hand Mirror Therapy

N/A

COMMIT mHealth application

Hiv

N/A

Clinical Trials (1)

NCT04462679COMMIT HIV Trial Nepal

N/A

Intervention Technology

Low Back Pain

N/A

Clinical Trials (1)

NCT03478007Low-Cost Tool for Compliance and Treatment-Tracking of Low Back Pain Patients

N/A

Conventional burger

Cardiometabolic Health

N/A

Clinical Trials (1)

NCT05582720Cardioprotective Properties of Vegan Burger

N/A

Cone Beam Computed Tomography

Healthy Ankle

N/A

Clinical Trials (1)

NCT03619382An Evaluation Of Healthy Ankle Motion And Morphology

N/A

Study Of Use Of Pemetrexed In Patients With Non-Small Lung Cancer Metastatic In Andalusian Public He

Carcinoma, Non-Small-Cell Lung

N/A

Clinical Trials (1)

NCT01877902Study Of Use Of Pemetrexed In Patients With Non-Small Lung Cancer Metastatic In Andalusian Public Health System

N/A

Hepatic Safety of Eviplera® in HIV/Hepatitis C (HCV)-Coinfected Patients Without HCV Treatment in th

Human Immunodeficiency Virus (HIV) Hepatitis C Virus (HCV) Coinfected Subjects

N/A

Clinical Trials (1)

NCT02196064Hepatic Safety of Eviplera® in HIV/Hepatitis C (HCV)-Coinfected Patients Without HCV Treatment in the "The HEPAVIR HEPATIC SAFETY Cohort."

N/A

Intervention: Mental Health Technician

Depression

N/A

Clinical Trials (1)

NCT02345122CAMH PARTNERs Integrated Care Study

N/A

Microbiological studies

Bacteremia by Enterobacteriaceae

N/A

Clinical Trials (1)

NCT02005159Study of the Impact of the Minimum Inhibitory Concentration and Susceptible Cut-off Points (CLSI, EUCAST, and Pharmacokinetics/Pharmacodynamics)in Prognosis of Bacteremia by Enterobacteriaceae

N/A

Coronary stent procedure

Unprotected Left Main Coronary Artery Stenosis

N/A

Clinical Trials (1)

NCT01971749Register of Treatment of Unprotected Left Main Coronary Artery Stenosis in Andalucía

N/A

Insole and ankle device

Mild Cognitive Impairment (MCI)

N/A

Clinical Trials (1)

NCT07127133An Insole and Ankle Device for Monitoring Cognitive Decline in Individuals at Risk for Alzheimer's Disease and/or Alzheimer's Disease Related Dementias (AD/ADRD)

N/A

Rehabilitation combined to a digital maintenance program

Post-COVID-19 Syndrome

N/A

Clinical Trials (1)

NCT06124625Effects of Rehabilitation Combined With a Maintenance Program Compared to Rehabilitation Alone in Post-COVID-19

N/A

Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Ca

Healthy Subjects

N/A

Clinical Trials (1)

NCT02890147Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Case-control

N/A

ZenctuaryVR+ Interactive Virtual Reality

Palliative Care

N/A

Clinical Trials (1)

NCT07545928Single Arm, Monocentric, Pilot Feasibility Study on an Interactive Virtual Reality Program in 20 Complex In-clinic Palliative Care Patients

N/A

SOONER Video & Kit

Opioid Use

N/A

Clinical Trials (1)

NCT04740099Surviving Opioid Overdose With Naloxone Education and Resuscitation Trial (SOONER)

N/A

Walkasins

Mild Cognitive Impairment

N/A

Clinical Trials (1)

NCT05723822Effects of Walkasins on Gait Speed of Individuals With Mild Cognitive Impairments